Landscape Capital Management’s Ocular Therapeutix OCUL Stock Holding History

Landscape Capital Management’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$131K	Sell	15,487 -6	-0%	-$57	0.01%	664
2025 Q4	$188K	Buy	+15,493	New	+$188K	0.01%	618
2024 Q2	–	Sell	-23,039	Closed	-$210K	–	848
2024 Q1	$210K	Buy	+23,039	New	+$164K	0.02%	605
2017 Q4	–	Sell	-11,289	Closed	-$70K	–	721
2017 Q3	$70K	Buy	+11,289	New	+$72.7K	0.01%	486
2016 Q1	–	Sell	-35,665	Closed	-$334K	–	747
2015 Q4	$334K	Buy	+35,665	New	+$385K	0.04%	654

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Landscape Capital Management's OCUL Position: Q1 2026 in Review

Landscape Capital Management reduced its Ocular Therapeutix (OCUL) stake by 0.04% in Q1 2026, selling an estimated $57 and leaving 15,487 shares worth $131K. The position accounts for 0.01% of the portfolio, ranked #664.

Landscape Capital Management first reported a position in OCUL in Q4 2015 and has held it in 5 quarters since. The position peaked at $334K in Q4 2015. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

Landscape Capital Management held 15,487 shares of Ocular Therapeutix worth $131K as of Q1 2026.
Landscape Capital Management sold 6 Ocular Therapeutix shares in Q1 2026, an estimated $57.
Ocular Therapeutix made up 0.01% of Landscape Capital Management's portfolio in Q1 2026, its #664 holding.
Landscape Capital Management first reported a position in Ocular Therapeutix in Q4 2015 and has held it in 5 quarters since.
Landscape Capital Management's Ocular Therapeutix position peaked at $334K in Q4 2015.
269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.